Atlas Trials

Safety and Efficacy of Eltrombopag at Escalated Doses

Clinical trial NCT01880047 · COMPLETED

Trial details

NCT number
NCT01880047
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Immune ThrombocytopeniaPlatelet Disorder
Start date
2013-02-01
Primary completion
2017-02-15
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.